Jasper Therapeutics (JSPR) Q4 2023 Earnings

4MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.61
-1.12
-0.64
-0.15

Details

Expected EPS
-1.608675
Actual EPS
-1.5
Surprise EPS
0.11
Surprise Percent
+6.76%

Description

Jasper Therapeutics (JSPR) has reported earnings of -1.5 per share for Q4 2023.

0 Comments

Share your thoughts